Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria

Phenylketonuria (PKU) is a genetic metabolic disease in which the decrease or loss of phenylalanine hydroxylase (PAH) activity results in elevated, neurotoxic levels of phenylalanine (Phe). Due to many obstacles, PAH enzyme replacement therapy is not currently an option. Treatment of PKU with an alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Sean M., Wendt, Dan J., Zhang, Yanhong, Taylor, Timothy W., Long, Shinong, Tsuruda, Laurie, Zhao, Bin, Laipis, Phillip, Fitzpatrick, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345807/
https://www.ncbi.nlm.nih.gov/pubmed/28282402
http://dx.doi.org/10.1371/journal.pone.0173269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345807/
https://www.ncbi.nlm.nih.gov/pubmed/28282402
http://dx.doi.org/10.1371/journal.pone.0173269

Ejemplares similares